Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

July 31, 2024

Study Completion Date

August 31, 2026

Conditions
Low Grade Glioma
Interventions
DRUG

Vinblastine

DRUG

Bevacizumab

Trial Locations (21)

19104

The Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

30322

Children's Healthcare of Atlanta, Atlanta

80045

Children's Hospital Colorado, Aurora

90027

Children's Hospital Los Angeles, Los Angeles

Unknown

Children's Hospital at Westmead, Westmead

Queensland Children's Hospital, South Brisbane

Women's and Children's Hospital, North Adelaide

Royal Children's Hospital, Parkville

Perth Children's Hospital, Nedlands

Alberta Children's Hospital, Calgary

Stollery Children's Hospital, Edmonton

BC Children's Hospital, Vancouver

Cancer Care Manitoba, Winnipeg

McMaster Children's Hospital, Hamilton

Children's Hospital - London Health Sciences Centre, London

Centre Hospitalier Universitaire Sainte-Justine, Montreal

Montreal Children's Hospital, Montreal

CHU du Quebec-Universite Laval, Québec

Starship Children's Hospital, Grafton

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

The Hospital for Sick Children

OTHER